Literature DB >> 6768092

An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD).

R E Thieme, H Dijkstra, J C Stoof.   

Abstract

Three main symptoms of minimal brain dysfunction (MBD), a common disorder in children, are hyperactivity, learning disabilities, and attention deficits. Drugs like amphetamine and methylphenidate have been demonstrated to produce a significant behavioral improvement in these children. The behavioral response of young rats (3--4 weeks), with selective lesioning of the central dopaminergic system, to a novel environment was analyzed. Both the frequencies and durations of eight mutually exclusive and complementary behavioral categories were scored. By analyzing the behavior in this way it appeared that considerable hyperactivity and learning disabilities could be demonstrated in these rats. Moreover, the bout length of some behavioral categories was somewhat shortened, which might be an indication of deficits in attention. However, treatment of the animals with amphetamine did not produce any "therapeutic" effect on the three symptoms. Since pharmacotherapeutic support is, in our opinion, a "conditio sine qua non" for the validity of the model, we do not believe that the young DA-lesioned rat is an appropriate animal model for MBD.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768092     DOI: 10.1007/bf00431972

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction.

Authors:  B A Shaywitz; R D Yager; J H Klopper
Journal:  Science       Date:  1976-01-23       Impact factor: 47.728

Review 2.  Pharmacology and neurochemistry of apomorphine.

Authors:  G Di Chiara; G L Gessa
Journal:  Adv Pharmacol Chemother       Date:  1978

3.  Dextroamphetamine sulfate in children with learning disorders. Effects on perception, learning, and achievement.

Authors:  C K Conners; G Rothschild; L Eisenberg; L S Schwartz; E Robinson
Journal:  Arch Gen Psychiatry       Date:  1969-08

4.  A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.

Authors:  M K Shellenberger; J H Gordon
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

5.  Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.

Authors:  R D Smith; B R Cooper; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

6.  Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

7.  Behavioural effects of methylphenidate in 6-hydroxydopamine-treated neonatal rats.

Authors:  S M Eastgate; J J Wright; J S Werry
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

8.  The effect of methylphenidate (ritalin) on sustained attention in hyperactive children.

Authors:  D H Sykes; V I Douglas; G Morgenstern
Journal:  Psychopharmacologia       Date:  1972

9.  Changes in the behavioral response to a novel environment following lesioning of the central dopaminergic system in rat pups.

Authors:  J C Stoof; H Duijkstra; J P Hillegers
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

10.  Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance.

Authors:  B A Shaywitz; J H Klopper; J W Gordon
Journal:  Arch Neurol       Date:  1978-07
View more
  4 in total

Review 1.  A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system.

Authors:  D E Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

2.  Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.

Authors:  J Luthman; A Fredriksson; T Lewander; G Jonsson; T Archer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.

Authors:  E Hard; S Ahlenius; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.

Authors:  Ryszard Brus; Przemyslaw Nowak; Ryszard Szkilnik; Urszula Mikolajun; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.